These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19885619)

  • 1. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.
    Chen J; Watanabe M; Huang P; Sakaguchi M; Ochiai K; Nasu Y; Ouchida M; Huh NH; Shimizu K; Kashiwakura Y; Kaku H; Kumon H
    Int J Mol Med; 2009 Dec; 24(6):789-94. PubMed ID: 19885619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model.
    Edamura K; Nasu Y; Takaishi M; Kobayashi T; Abarzua F; Sakaguchi M; Kashiwakura Y; Ebara S; Saika T; Watanabe M; Huh NH; Kumon H
    Cancer Gene Ther; 2007 Sep; 14(9):765-72. PubMed ID: 17599093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.
    Watanabe M; Kashiwakura Y; Huang P; Ochiai K; Futami J; Li SA; Takaoka M; Nasu Y; Sakaguchi M; Huh NH; Kumon H
    Int J Oncol; 2009 Mar; 34(3):657-63. PubMed ID: 19212670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.
    Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kurose K; Ebara S; Miyazaki M; Namba M; Kumon H; Huh NH
    Cancer Res; 2005 Nov; 65(21):9617-22. PubMed ID: 16266978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3.
    Tanimoto R; Sakaguchi M; Abarzua F; Kataoka K; Kurose K; Murata H; Nasu Y; Kumon H; Huh NH
    Int J Cancer; 2010 Apr; 126(7):1562-9. PubMed ID: 19626590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.
    Sawahara H; Shiraha H; Uchida D; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Nasu Y; Kumon H; Okada H
    Cancer Gene Ther; 2016 Aug; 23(8):278-83. PubMed ID: 27468808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REIC/Dkk-3 induces cell death in human malignant glioma.
    Mizobuchi Y; Matsuzaki K; Kuwayama K; Kitazato K; Mure H; Kageji T; Nagahiro S
    Neuro Oncol; 2008 Jun; 10(3):244-53. PubMed ID: 18443132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
    Uchida D; Shiraha H; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Yagi T; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2014 May; 29(5):973-83. PubMed ID: 24372695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition.
    Mori A; Watanabe M; Sadahira T; Kobayashi Y; Ariyoshi Y; Ueki H; Wada K; Ochiai K; Li SA; Nasu Y
    Acta Med Okayama; 2017 Apr; 71(2):135-142. PubMed ID: 28420895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.
    Ochiai K; Morimatsu M; Kato Y; Ishiguro-Oonuma T; Udagawa C; Rungsuriyawiboon O; Azakami D; Michishita M; Ariyoshi Y; Ueki H; Nasu Y; Kumon H; Watanabe M; Omi T
    Oncotarget; 2016 Jan; 7(3):3283-96. PubMed ID: 26658102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy.
    Sugimoto M; Watanabe M; Kaku H; Li SA; Noguchi H; Ueki H; Sakaguchi M; Huh NH; Nasu Y; Kumon H
    Oncol Rep; 2012 Nov; 28(5):1645-52. PubMed ID: 22941469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development.
    Zhang K; Watanabe M; Kashiwakura Y; Li SA; Edamura K; Huang P; Yamaguchi K; Nasu Y; Kobayashi Y; Sakaguchi M; Ochiai K; Yamada H; Takei K; Ueki H; Huh NH; Li M; Kaku H; Na Y; Kumon H
    Int J Oncol; 2010 Dec; 37(6):1495-501. PubMed ID: 21042718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis.
    Abarzua F; Kashiwakura Y; Takaoka M; Watanabe M; Ochiai K; Sakaguchi M; Iwawaki T; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Biochem Biophys Res Commun; 2008 Oct; 375(4):614-8. PubMed ID: 18727918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of the feline tumour suppressor reduced expression in immortalized cells (REIC/Dkk-3).
    Ochiai K; Oda H; Shono S; Kato Y; Sugihara S; Nakazawa S; Azakami D; Michishita M; Onozawa E; Bonkobara M; Sako T; Shun-Ai L; Ueki H; Watanabe M; Omi T
    Vet Comp Oncol; 2017 Dec; 15(4):1181-1186. PubMed ID: 27353749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression.
    Kinoshita R; Watanabe M; Huang P; Li SA; Sakaguchi M; Kumon H; Futami J
    Oncol Rep; 2015 Jun; 33(6):2908-14. PubMed ID: 25823913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
    Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
    Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
    PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy.
    Oka T; Kurozumi K; Shimazu Y; Ichikawa T; Ishida J; Otani Y; Shimizu T; Tomita Y; Sakaguchi M; Watanabe M; Nasu Y; Kumon H; Date I
    Sci Rep; 2016 Sep; 6():33319. PubMed ID: 27625116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.